Genetics of depression: Implications for clinical practice yet?

Clinical Neuropsychiatry

Volumn 8, Issue 1, 2011, Pages 37-46

  Garriock, Holly A ^a   Moreno, Francisco A ^b  

^a NATIONAL INSTITUTE OF MENTAL HEALTH   (United States)

^b UNIVERSITY OF ARIZONA   (United States)

Author keywords

Antidepressant response; Genetics; Major depressive disorder; Pharmacokinetic genes; Phenotypic outcome

Indexed keywords

ACTIVATING TRANSCRIPTION FACTOR 2; ANTIDEPRESSANT AGENT; BRAIN DERIVED NEUROTROPHIC FACTOR; CITALOPRAM; CYTOCHROME P450; FK 506 BINDING PROTEIN; KAINIC ACID RECEPTOR; MU OPIATE RECEPTOR; MULTIDRUG RESISTANCE PROTEIN 1; PHOSPHODIESTERASE 4A; PHOSPHODIESTERASE IV; PROTEIN GRIK4; PROTEIN TREK1; SEROTONIN 2A RECEPTOR; SEROTONIN TRANSPORTER; TRYPTOPHAN HYDROXYLASE; UNCLASSIFIED DRUG;

ADOPTION; ARTICLE; CLINICAL DECISION MAKING; CLINICAL GENETICS; CLINICAL PRACTICE; FAMILY; GENE EXPRESSION; GENE FREQUENCY; GENE IDENTIFICATION; GENETIC ALGORITHM; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC HETEROGENEITY; GENETIC MARKER; GENETIC RISK; GENETIC SCREENING; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; HERITABILITY; HUMAN; MAJOR DEPRESSION; MOLECULAR GENETICS; PHARMACOGENETICS; PHENOTYPE; PREDICTION; SINGLE NUCLEOTIDE POLYMORPHISM; TWINS;

EID: 79955608149     PISSN: 17244935     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (105)

1. Andreasen NC, Rice J, Endicott J, Coryell W, Grove WM, Reich T (1987). Familial rates of affective disorder. A report from the National Institute of Mental Health Collaborative Study. Arch Gen Psychiatry 44, 5, 461-9.
2. Bellivier F, Leboyer M, Courtet P, Buresi C, Beaufils B, Samolyk D, Allilaire JF, Feingold J, Mallet J, Malafosse A (1998). Association between the tryptophan hydroxylase gene and manic-depressive illness. Arch Gen Psychiatry 55,1, 33-7.
3. Binder EB, Salyakina D, Lichtner P, Wochnik GM, Ising M, Piitz B, Papiol S, Seaman S, Lucae S, Kohli MA, Nickel T, Kiinzel HE, Fuchs B, Majer M, Pfennig A, Kern N, Brunner J, Modell S, Baghai T, Deiml T, Zill P, Bondy B, Rupprecht R, Messer T, Kohnlein O, Dabitz H, Briickl T, Miiller N, Pfister H, Lieb R, Mueller JC, Lohmussaar E, Strom TM, Bettecken T, Meitinger T, Uhr M, Rein T, Holsboer F, Muller-Myhsok B (2004). Polymorphisms in FKBP5 are associated with increased recurrence of depressive episodes and rapid response to antidepressant treatment. Nat Genet 36,12, 1319-25.
4. Bland RC, Newman SC, Orn H (1986). Recurrent and nonrecurrent depression. A family study. Arch Gen Psychiatry 43, 11, 1085-9.
5. Braun NN, Reutiman TJ, Lee S, Folsom TD, Fatemi SH (2007). Expression of phosphodiesterase 4 is altered in the brains of subjects with autism. Neuroreport 18, 17, 1841-4.
6. Cadoret RJ (1978). Evidence for genetic inheritance of primary affective disorder in adoptees. Am J Psychiatry 135, 4, 463-6.
7. Camp NJ, Lowry MR, Richards RL, Plenk AM, Carter C, Hensel CH, Abkevich V, Skolnick MH, Shattuck D, Rowe KG, Hughes DC, Cannon-Albright LA (2005). Genome-wide linkage analyses of extended Utah pedigrees identifies loci that influence recurrent, early-onset major depression and anxiety disorders. Am J Med Genet B Neuropsychiatr Genet 135B, 1, 85-93.
8. Caspi A, Sugden K, Moffitt TE, Taylor A, Craig IW, Harrington H, McClay J, Mill J, Martin J, Braithwaite A, Poulton R (2003). Influence of life stress on depression: moderation by a polymorphism in the 5-HTT gene. Science 301, 5631, 386-9.
9. Duman RS, Heninger GR, Nestler EJ (1997). A molecular and cellular theory of depression. Arch Gen Psychiatry 54, 7, 597-606.
10. EGAPP (2007). Recommendations from the EGAPP Working Group: testing for cytochrome P450 polymorphisms in adults with nonpsychotic depression treated with selective serotonin reuptake inhibitors. Genet Med 9, 12, 819-25.
11. Eley TC, Sugden K, Corsico A, Gregory AM, Sham P, McGuffin P, Plomin R, Craig IW (2004). Gene-environment interaction analysis of serotonin system markers with adolescent depression. Mol Psychiatry 9, 10, 908-15.
12. Garriock HA, Allen JJ, Delgado P, Nahaz Z, Kling MA, Carpenter L, Burke M, Burke W, Schwartz T, Marangell LB, Husain M, Erickson RP, Moreno FA (2005). Lack of association of TPH2 exon XI polymorphisms with major depression and treatment resistance. Mol Psychiatry 10, 11, 976-7.
13. Garriock HA, Hamilton SP (2009a). Genetic studies of drug response and side effects in the STAR*D study, part 1. J Clin Psychiatry 70, 8, 1186-7.
14. Garriock HA, Hamilton SP (2009b). Genetic studies of drug response and side effects in the STAR*D study, part 2. J Clin Psychiatry 70, 9, 1323-5.
15. Garriock HA, Kraft JB, Shyn SI, Peters EJ, Yokoyama JS, Jenkins GD, Reinalda MS, Slager SL, McGrath PJ, Hamilton SP (2010). A genomewide association study of citalopram response in major depressive disorder. Biol Psychiatry 67, 2, 133-8.
16. Garriock HA, Tanowitz M, Kraft JB, Dang VC, Peters EJ, Jenkins GD, Reinalda MS, McGrath PJ, von Zastrow M, Slager SL, Hamilton SP (2010). Association of mu-opioid receptor variants and response to citalopram treatment in major depressive disorder. Am J Psychiatry 167, 5, 565-73.
17. Gershon ES, Hamovit J, Guroff JJ, Dibble E, Leckman JF, Sceery W, Targum SD, Nurnberger JI Jr, Goldin LR, Bunney WE Jr (1982). A family study of schizoaffective, bipolar I, bipolar II, unipolar, and normal control probands. Arch Gen Psychiatry 39, 10, 1157-67.
18. Gillespie NA, Whitfield JB, Williams B, Heath AC, Martin NG (2005). The relationship between stressful life events, the serotonin transporter (5-HTTLPR) genotype and major depression. Psychol Med 35, 1, 101-11.
19. Grabe HJ, Lange M, Wolff B, Volzke H, Lucht M, Freyberger HJ, John U, Cascorbi I (2005). Mental and physical distress is modulated by a polymorphism in the 5-HT transporter gene interacting with social stressors and chronic disease burden. Mol Psychiatry 10, 2, 220-4.
20. Haghighi F, Bach-Mizrachi H, Huang YY, Arango V, Shi S, Dwork AJ, Rosoklija G, Sheng HT, Morozova I, Ju J, Rus-so JJ, Mann JJ (2008). Genetic architecture of the human tryptophan hydroxylase 2 Gene: existence of neural isoforms and relevance for major depression. Mol Psychiatry 13, 8, 813-20
21. Harrington R, Rutter M, Weissman M, Fudge H, Groothues C, Bredenkamp D, Pickles A, Rende R, Wickramaratne P (1997). Psychiatric disorders in the relatives of depressed probands. I. Comparison of prepubertal, adolescent and early adult onset cases. J Affect Disord 42, 1, 9-22.
22. Heils A, Teufel A, Petri S, Stober G, Riederer P, Bengel D, Lesch KP (1996). Allelic variation of human serotonin transporter gene expression. JNeurochem 66, 6, 2621-4.
23. Holmans P, Zubenko GS, Crowe RR, DePaulo JR Jr, Scheftner WA, Weissman MM, Zubenko WN, Boutelle S, Murphy-Eberenz K, MacKinnon D, McInnis MG, Marta DH, Adams P, Knowles JA, Gladis M, Thomas J, Chellis J, Miller E, Levinson DF (2004). Genomewide significant linkage to recurrent, early-onset major depressive disorder on chromosome 15q. Am J Hum Genet 74, 6, 1154-67.
24. Hu XZ, Rush AJ, Charney D, Wilson AF, Sorant AJ, Papanicolaou GJ, Fava M, Trivedi MH, Wisniewski SR, Laje G, Paddock S, McMahon FJ, Manji H, Lipsky RH (2007). Association between a functional serotonin transporter promoter polymorphism and citalopram treatment in adult outpatients with major depression. Arch Gen Psychiatry 64, 7, 783-92.
25. Iga J, Ueno S, Yamauchi K, Numata S, Tayoshi-Shibuya S, Kinouchi S, Nakataki M, Song H, Hokoishi K, Tanabe H, Sano A, Ohmori T (2007). The Val66Met polymorphism of the brain-derived neurotrophic factor gene is associated with psychotic feature and suicidal behavior in Japanese major depressive patients. Am J Med Genet B Neuro-psychialr Genet 144B, 8, 1003-6.
26. Ising M, Lucae S, Binder EB, Bettecken T, Uhr M, Ripke S, Kohli MA, Hennings JM, Horstmann S, Kloiber S, Menke A, Bondy B, Rupprecht R, Domschke K, Baune BT, Arolt V, Rush AJ, Holsboer F, Miiller-Myhsok B (2009). A genomewide association study points to multiple loci that predict antidepressant drug treatment outcome in depression. Arch Gen Psychiatry 66, 9, 966-75.
27. Jacobs N, Kenis G, Peeters F, Derom C, Vlietinck R, van Os J (2006). Stress-related negative affectivity and genetically altered serotonin transporter function: evidence of synergism in shaping risk of depression. Arch Gen Psychiatry 63, 9, 989-96.
28. Kaufman J, Yang BZ, Douglas-Palumberi H, Grasso D, Lipschitz D, Houshyar S, Krystal JH, Gelernter J (2006). Brain-derived neurotrophic factor-5-HTTLPR gene interactions and environmental modifiers of depression in children. Biol Psychiatry 59, 8, 673-80.
29. Kaufman J, Yang BZ, Douglas-Palumberi H, Houshyar S, Lipschitz D, Krystal JH, Gelernter J (2004). Social supports and serotonin transporter gene moderate depression in maltreated children. Proc Natl Acad Sci U S A 101, 49, 17316-21.
30. Kendler KS, Kuhn JW, Vittum J, Prescott CA, Riley B (2005). The interaction of stressful life events and a serotonin transporter polymorphism in the prediction of episodes of major depression: a replication. Arch Gen Psychiatry 62, 5, 529-35.
31. Kilpatrick DG, Koenen KC, Ruggiero KJ, Acierno R, Galea S, Resnick HS, Roitzsch J, Boyle J, Gelernter J (2007). The serotonin transporter genotype and social support and moderation of posttraumatic stress disorder and depression in hurricane-exposed adults. Am J Psychiatry 164, 11, 1693-9.
32. Kraft JB, Peters EJ, Slager SL, Jenkins GD, Reinalda MS, McGrath PJ, Hamilton SP (2007). Analysis of association between the serotonin transporter and antidepressant response in a large clinical sample. Biol Psychiatry 61, 6, 734-42.
33. Kurian SM, Le-Niculescu H, Patel SD, Bertram D, Davis J, Dike C, Yehyawi N, Lysaker P, Dustin J, Caligiuri M, Lohr J, Lahiri DK, Nurnberger JI Jr, Faraone SV, Geyer MA, Tsuang MT, Schork NJ, Salomon DR, Niculescu AB (2009). Identification of blood biomarkers for psychosis using convergent functional genomics. Mol Psychiatry Nov 24. [Epub ahead of print]
34. Laje G, Allen AS, Akula N, Manji H, John Rush A, McMahon FJ (2009). Genome-wide association study of suicidal ideation emerging during citalopram treatment of depressed outpatients. Pharmacogenet Genomics 19, 9, 666-74.
35. Le-Niculescu H, Kurian SM, Yehyawi N, Dike C, Patel SD, Edenberg HJ, Tsuang MT, Salomon DR, Nurnberger JI Jr, Niculescu AB (2009). Identifying blood biomarkers for mood disorders using convergent functional genomics. Mol Psychiatry 14, 2, 156-74.
36. Lekman M, Laje G, Charney D, Rush AJ, Wilson AF, Sorant AJ, Lipsky R, Wisniewski SR, Manji H, McMahon FJ, Paddock S (2008). The FKBP5-Gene in Depression and Treatment Response-an Association Study in the Sequenced Treatment Alternatives to Relieve Depression (STAR*D) Cohort. Biol Psychiatry 63,12,1103-10
37. Lesch KP, Bengel D, Heils A, Sabol SZ, Greenberg BD, Petri S, Benjamin J, Miiller CR, Hamer DH, Murphy DL (1996). Association of anxiety-related traits with a polymorphism in the serotonin transporter gene regulatory region. Science 274, 5292, 1527-31.
38. Levinson DF, Evgrafov OV, Knowles JA, Potash JB, Weissman MM, Scheftner WA, Depaulo JR Jr, Crowe RR, Murphy-Eberenz K, Marta DH, McInnis MG, Adams P, Gladis M, Miller EB, Thomas J, Holmans P (2007). Genetics of recurrent early-onset major depression (GenRED): significant linkage on chromosome 15q25-q26 after fine mapping with single nucleotide polymorphism markers. Am J Psychiatry 164, 2, 259-64.
39. Liu X, Xu Y, Jiang S, Cui D, Qian Y, Jiang K (2009). Family-based association study between brain-derived neurotrophic factor gene and major depressive disorder of Chinese descent. Psychiatry Res 169, 2,169-72.
40. Liu Y, Blackwood DH, Caesar S, de Geus EJ, Farmer A, Ferreira MA, Ferrier IN, Fraser C, Gordon-Smith K, Green EK, Grozeva D, Gurling HM, Hamshere ML, Heutink P, Holmans PA, Hoogendijk WJ, Hottenga JJ, Jones L, Jones IR, Kirov G, Lin D, McGuffin P, Moskvina V, Nolen WA, Perlis RH, Posthuma D, Scolnick EM, Smit AB, Smit JH, Smoller JW, St Clair D, van Dyck R, Verhage M, Willemsen G, Young AH, Zandbelt T, Boomsma DI, Craddock N, O'Donovan MC, Owen MJ, Penninx BW, Purcell S, Sklar P, Sullivan PF (2010). Meta-analysis of genome-wide association data of bipolar disorder and major depressive disorder. Mol Psychiatry Mar 30. [Epub ahead of print]
41. Lotrich, F. E., B. G. Pollock, et al. (2008). Serotonin transporter genotype interacts with paroxetine plasma levels to influence depression treatment response in geriatric patients. J Psychiatry Neurosci 33, 2, 123-30.
42. Mann JJ, Huang YY, Underwood MD, Kassir SA, Oppenheim S, Kelly TM, Dwork AJ, Arango V (2000). A serotonin transporter gene promoter polymorphism (5-HTTLPR) and prefrontal cortical binding in major depression and suicide. Arch Gen Psychiatry 57, 8, 729-38.
43. Manuck SB, Flory JD, Ferrell RE, Dent KM, Mann JJ, Muldoon MF (1999). Aggression and anger-related traits associated with a polymorphism of the tryptophan hydroxylase gene. Biol Psychiatry 45, 5, 603-14.
44. McGuffin P, Katz R, Bebbington P (1987). Hazard, heredity and depression. A family study. J Psychiatr Res 21, 4,365-75.
45. McGuffin P, Knight J, Breen G, Brewster S, Boyd PR, Craddock N, Gill M, Korszun A, Maier W, Middleton L, Mors O, Owen MJ, Perry J, Preisig M, Reich T, Rice J, Rietschel M, Jones L, Sham P, Farmer AE (2005). Whole genome linkage scan of recurrent depressive disorder from the depression network study. Hum Mol Genet 14, 22, 3337-45.
46. McMahon FJ, Akula N, Schulze TG, Muglia P, Tozzi F, Detera-Wadleigh SD, Steele CJ, Breuer R, Strohmaier J, Wendland JR, Mattheisen M, Miihleisen TW, Maier W, Nothen MM, Cichon S, Farmer A, Vincent JB, Holsboer F, Preisig M, Rietschel M; Bipolar Disorder Genome Study (BiGS) Consortium (2010). Meta-analysis of genome-wide association data identifies a risk locus for major mood disorders on 3p21.1.Nat Genet 42, 2,128-31.
47. McMahon FJ, Buervenich S, Charney D, Lipsky R, Rush AJ, Wilson AF, Sorant AJ, Papanicolaou GJ, Laje G, Fava M, Trivedi MH, Wisniewski SR, Manji H (2006). Variation in the gene encoding the serotonin 2A receptor is associated with outcome of antidepressant treatment. Am J Hum Genet 78, 5, 804-14.
48. Mendlewicz J, Rainer JD (1977). Adoption study supporting genetic transmission in manic-depressive illness. Nature 268, 5618, 327-9.
49. Merikangas KR, Prusoff BA, Weissman MM (1988). Parental concordance for affective disorders: psychopathology in offspring. J Affect Disord 15, 3, 279-90.
50. Middeldorp CM, Sullivan PF, Wray NR, Hottenga JJ, de Geus EJ, van den Berg M, Montgomery GW, Coventry WL, Statham DJ, Andrews G, Slagboom PE, Boomsma DI, Martin NG (2009). Suggestive linkage on chromosome 2, 8, and 17 for lifetime major depression. Am J Med Genet B Neuropsychiatr Genet 150B, 3, 352-8.
51. Mitchell J, McCauley E, Burke P, Calderon R, Schloredt K (1989). Psychopathology in parents of depressed children and adolescents.J Am Acad ChildAdolesc Psychiatry 28, 3, 352-7.
52. Moreno FA, Rowe DC, Kaiser B, Chase D, Michaels T, Gelernter J, Delgado PL (2002). Association between a serotonin transporter promoter region polymorphism and mood response during tryptophan depletion. Mol Psychiatry 7, 2, 213-6.
53. Mrazek DA, Rush AJ, Biernacka JM, O'Kane DJ, Cunningham JM, Wieben ED, Schaid DJ, Drews MS, Courson VL, Snyder KA, Black JL 3rd, Weinshilboum RM (2009). SLC6A4 variation and citalopram response. Am J Med Genet B Neuropsychiatr Genet 150B, 3, 341-51.
54. Muglia P, Tozzi F, Galwey NW, Francks C, Upmanyu R, Kong XQ, Antoniades A, Domenici E, Perry J, Rothen S, Vandeleur CL, Mooser V, Waeber G, Vollenweider P, Preisig M, Lucae S, Miller-Myhsok B, Holsboer F, Middleton LT, Roses AD (2010). Genome-wide association study of recurrent major depressive disorder in two European case-control cohorts. Mol Psychiatry 15, 6, 589-601.
55. Murphy GM Jr, Kremer C, Rodrigues HE, Schatzberg AF (2003). Pharmacogenetics of antidepressant medication intolerance. Am J Psychiatry 160, 10, 1830-5.
56. Murphy GM Jr, SB Hollander, et al. (2004). Effects of the serotonin transporter gene promoter polymorphism on mirtazapine and paroxetine efficacy and adverse events in geriatric major depression. Arch Gen Psychiatry 61, 11, 1163-9.
57. Nash MW, Sugden K, Huezo-Diaz P, Williamson R, Sterne A, Purcell S, Sham PC, Craig IW (2005). Association analysis of monoamine genes with measures of depression and anxiety in a selected community sample of siblings. Am J Med Genet B Neuropsychiatr Genet 135, 1, 33-7.
58. Neves-Pereira M, Mundo E, Muglia P, King N, Macciardi F, Kennedy JL (2002). The brain-derived neurotrophic factor gene confers susceptibility to bipolar disorder: evidence from a family-based association study. Am J Hum Genet 71, 3, 651-5.
59. Paddock S, Laje G, Charney D, Rush AJ, Wilson AF, Sorant AJ, Lipsky R, Wisniewski SR, Manji H, McMahon FJ (2007). Association of GRIK4 with outcome of antidepressant treatment in the STAR*D cohort. Am J Psychiatry 164, 8, 1181-8.
60. Patel SD, Le-Niculescu H, Koller DL, Green SD, Lahiri DK, McMahon FJ, Nurnberger JI Jr, Niculescu AB 3rd (2010). Coming to grips with complex disorders: genetic risk prediction in bipolar disorder using panels of genes identified through convergent functional genomics. Am J Med Genet B Neuropsychiatr Genet 153B, 4, 850-77.
61. Perlis RH, Moorjani P, Fagerness J, Purcell S, Trivedi MH, Fava M, Rush AJ, Smoller JW (2008). Pharmacogenetic Analysis of Genes Implicated in Rodent Models of Antidepressant Response: Association of TREK1 and Treatment Resistance in the STAR(*)D Study. Neuropsycho-pharmacology 33, 12, 2810-9
62. Perlis RH, A Patrick, et al. (2009). When is pharmacogenetic testing for antidepressant response ready for the clinic? A cost-effectiveness analysis based on data from the STAR*D study. Neuropsychopharmacology 34, 10, 2227-36.
63. Peters EJ, Slager SL, Jenkins GD, Reinalda MS, Garriock HA, Shyn SI, Kraft JB, McGrath PJ, Hamilton SP (2009). Resequencing of serotonin-related genes and association of tagging SNPs to citalopram response. Pharmacogenet Genomics 19,1, 1-10.
64. Peters EJ, Slager SL, Kraft JB, Jenkins GD, Reinalda MS, McGrath PJ, Hamilton SP (2008). Pharmacokinetic genes do not influence response or tolerance to citalopram in the STAR*D sample. PLoS ONE 3, 4, e1872.
65. Pickard BS, Thomson PA, Christoforou A, Evans KL, Morris SW, Porteous DJ, Blackwood DH, Muir WJ (2007). The PDE4B gene confers sex-specific protection against schizophrenia. Psychiatr Genet 17, 3, 129-33.
66. Rende R, Weissman M, Rutter M, Wickramaratne P, Harrington R, Pickles A (1997). Psychiatric disorders in the relatives of depressed probands. II. Familial loading for comorbid non-depressive disorders based upon proband age of onset. J Affect Disord 42, 1, 23-8.
67. Rietschel M, Schorr A, Albus M, Franzek E, Kreiner R, Held T, Knapp M, Miller DJ, Schulze TG, Propping P, Maier W, Nöthen MM (2000). Association study of the tryptophan hydroxylase gene and bipolar affective disorder using family-based internal controls. Am J Med Genet 96, 3, 310-1.
68. Risch N, Herrell R, Lehner T, Liang KY, Eaves L, Hoh J, Griem Kovacs M, Ott J, Merikangas KR (2009). Interaction between the serotonin transporter gene (5-HTTLPR), stressful life events, and risk of depression: a meta-analysis. JAMA 301, 23, 2462-71.
69. Rotondo A, Schuebel K, Bergen A, Aragon R, Virkkunen M, Linnoila M, Goldman D, Nielsen D (1999). Identification of four variants in the tryptophan hydroxylase promoter and association to behavior. Mol Psychiatry 4, 4, 360-8.
70. Rush AJ, Fava M, Wisniewski SR, Lavori PW, Trivedi MH, Sackeim HA, Thase ME, Nierenberg AA, Quitkin FM, Kashner TM, Kupfer DJ, Rosenbaum JF, Alpert J, Stewart JW, McGrath PJ, Biggs MM, Shores-Wilson K, Lebowitz BD, Ritz L, Niederehe G; STAR*D Investigators Group (2004). Sequenced treatment alternatives to relieve depression (STAR*D): rationale and design. Control Clin Trials 25, 1, 119-42.
71. Schmidt HD, Duman RS (2007). The role of neurotrophic factors in adult hippocampal neurogenesis, antidepressant treatments and animal models of depressive-like behavior. Behav Pharmacol 18, 5-6, 391-418.
72. Serretti A, Lilli R, Lorenzi C, Gasperini M, Smeraldi E (1999). Tryptophan hydroxylase gene and response to lithium prophylaxis in mood disorders. J Psychiatr Res 33, 5, 3717.
73. Shi J, Potash JB, Knowles JA, Weissman MM, Coryell W, Scheftner WA, Lawson WB, Depaulo JR Jr, Gejman PV, Sanders AR, Johnson JK, Adams P, Chaudhury S, Jancic D, Evgrafov O, Zvinyatskovskiy A, Ertman N, Gladis M, Neimanas K, Goodell M, Hale N, Ney N, Verma R, Mirel D, Holmans P, Levinson DF (2010). Genome-wide association study of recurrent early-onset major depressive disorder. Mol Psychiatry Feb 2. [Epub ahead of print]
74. Shifman S, Bhomra A, Smiley S, Wray NR, James MR, Martin NG, Hettema JM, An SS, Neale MC, van den Oord EJ, Kendler KS, Chen X, Boomsma DI, Middeldorp CM, Hottenga JJ, Slagboom PE, Flint J (2008). A whole genome association study of neuroticism using DNA pooling. Mol Psychiatry 13, 3, 302-12.
75. Shyn SI, Shi J, Kraft JB, Potash JB, Knowles JA, Weissman MM, Garriock HA, Yokoyama JS, McGrath PJ, Peters EJ, Scheftner WA, Coryell W, Lawson WB, Jancic D, Gejman PV, Sanders AR, Holmans P, Slager SL, Levinson DF, Hamilton SP. (2009). Novel loci for major depression identified by genome-wide association study of Sequenced Treatment Alternatives to Relieve Depression and meta-analysis of three studies. Mol Psychiatry Dec 29. [Epub ahead of print]
76. Sklar P, Smoller JW, Fan J, Ferreira MA, Perlis RH, Chambert K, Nimgaonkar VL, McQueen MB, Faraone SV, Kirby A, de Bakker PI, Ogdie MN, Thase ME, Sachs GS, Todd-Brown K, Gabriel SB, Sougnez C, Gates C, Blumenstiel B, Defelice M, Ardlie KG, Franklin J, Muir WJ, McGhee KA, MacIntyre DJ, McLean A, VanBeck M, McQuillin A, Bass NJ, Robinson M, Lawrence J, Anjorin A, Curtis D, Scolnick EM, Daly MJ, Blackwood DH, Gurling HM, Purcell SM (2008). Whole-genome association study of bipolar disorder. Mol Psychiatry 13, 6, 558-69.
77. Song Q, Cole JW, O'Connell JR, Stine OC, Gallagher M, Giles WH, Mitchell BD, Wozniak MA, Stern BJ, Sorkin JD, McArdle PF, Naj AC, Xu Q, Gibbons GH, Kittner SJ (2006). Phosphodiesterase 4D polymorphisms and the risk of cerebral infarction in a biracial population: the Stroke Prevention in Young Women Study. Hum Mol Genet 15, 16, 2468-78.
78. Souery D, Van Gestel S, Massat I, Blairy S, Adolfsson R, Blackwood D, Del-Favero J, Dikeos D, Jakovljevic M, Kaneva R, Lattuada E, Lerer B, Lilli R, Milanova V, Muir W, Nothen M, Oruc L, Papadimitriou G, Propping P, Schulze T, Serretti A, Shapira B, Smeraldi E, Stefanis C, Thomson M, Van Broeckhoven C, Mendlewicz J (2001). Tryptophan hydroxylase polymorphism and suicidality in unipolar and bipolar affective disorders: a multicenter association study. Biol Psychiatry 49, 5, 405-9.
79. Spijker S, Van Zanten JS, De Jong S, Penninx BW, van Dyck R, Zitman FG, Smit JH, Ylstra B, Smit AB, Hoogendijk WJ (2010). Stimulated Gene Expression Profiles as a Blood Marker of Major Depressive Disorder. Biological Psychiatry 68, 2, 179-86.
80. Sullivan PF, de Geus EJ, Willemsen G, James MR, Smit JH, Zandbelt T, Arolt V, Baune BT, Blackwood D, Cichon S, Coventry WL, Domschke K, Farmer A, Fava M, Gordon SD, He Q, Heath AC, Heutink P, Holsboer F, Hoogendijk WJ, Hottenga JJ, Hu Y, Kohli M, Lin D, Lucae S, Macintyre DJ, Maier W, McGhee KA, McGuffin P, Montgomery GW, Muir WJ, Nolen WA, Nothen MM, Perlis RH, Pirlo K, Posthuma D, Rietschel M, Rizzu P, Schosser A, Smit AB, Smoller JW, Tzeng JY, van Dyck R, Verhage M, Zitman FG, Martin NG, Wray NR, Boomsma DI, Penninx BW (2009). Genome-wide association for major depressive disorder: a possible role for the presynaptic protein piccolo. Mol Psychiatry 14, 4, 359-75.
81. Sullivan PF, Neale MC, Kendler KS (2000). Genetic epidemiology of major depression: review and metaanalysis. Am J Psychiatry 157, 10, 1552-62.
82. Surtees PG, Wainwright NW, Willis-Owen SA, Luben R, Day NE, Flint J (2006). Social adversity, the serotonin transporter (5-HTTLPR) polymorphism and major depressive disorder. Biol Psychiatry 59, 3, 224-9.
83. Tsai SJ, Hong CJ, Wang YC (1999). Tryptophan hydroxylase gene polymorphism (A218C) and suicidal behaviors. Neuroreport 10, 18, 3773-5.
84. Turecki G, Zhu Z, Tzenova J, Lesage A, Seguin M, Tousignant M, Chawky N, Vanier C, Lipp O, Alda M, Joober R, Benkelfat C, Rouleau GA (2001). TPH and suicidal behavior: a study in suicide completers. Mol Psychiatry 6, 1, 98-102.
85. Uher R, Perroud N, Ng MY, Hauser J, Henigsberg N, Maier W, Mors O, Placentino A, Rietschel M, Souery D, Zagar T, Czerski PM, Jerman B, Larsen ER, Schulze TG, Zobel A, Cohen-Woods S, Pirlo K, Butler AW, Muglia P, Barnes MR, Lathrop M, Farmer A, Breen G, Aitchison KJ, Craig I, Lewis CM, McGuffin P (2010). Genome-wide pharmacogenetics of antidepressant response in the GENDEP project. Am J Psychiatry 167, 5, 555-64.
86. Uhr M, Tontsch A, Namendorf C, Ripke S, Lucae S, Ising M, Dose T, Ebinger M, Rosenhagen M, Kohli M, Kloiber S, Salyakina D, Bettecken T, Specht M, Pitz B, Binder EB, Miller-Myhsok B, Holsboer F (2008). Polymorphisms in the drug transporter gene ABCB1 predict antidepressant treatment response in depression. Neuron 57, 2, 203-9.
87. Verma R, Holmans P, Knowles JA, Grover D, Evgrafov OV, Crowe RR, Scheftner WA, Weissman MM, DePaulo JR Jr, Potash JB, Levinson DF (2008). Linkage disequilibrium mapping of a chromosome 15q25-26 major depression linkage region and sequencing of NTRK3. Biol Psychiatry 63, 12, 1185-9.
88. von Knorring AL, Cloninger CR, Bohman M, Sigvardsson S (1983). An adoption study of depressive disorders and substance abuse. Arch Gen Psychiatry 40, 9, 943-50.
89. W.T.C.C. (2007). Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls. Nature 447, 7145, 661-78.
90. Weissman MM, Gammon GD, John K, Merikangas KR, Warner V, Prusoff BA, Sholomskas D. (1987). Children of depressed parents. Increased psychopathology and early onset of major depression. Arch Gen Psychiatry 44, 10, 847-53.
91. Weissman MM, Gershon ES, Kidd KK, Prusoff BA, Leckman JF, Dibble E, Hamovit J, Thompson WD, Pauls DL, Guroff JJ (1984). Psychiatric disorders in the relatives of probands with affective disorders. The Yale University-National Institute of Mental Health Collaborative Study. Arch Gen Psychiatry 41, 1, 13-21.
92. Weissman MM, Warner V, Wickramaratne P, Prusoff BA (1988). Early-onset major depression in parents and their children. J Affect Disord 15, 3, 269-77.
93. Wender PH, Kety SS, Rosenthal D, Schulsinger F, Ortmann J, Lunde I (1986). Psychiatric disorders in the biological and adoptive families of adopted individuals with affective disorders. Arch Gen Psychiatry 43, 10, 923-9.
94. Wilhelm K, Mitchell PB, Niven H, Finch A, Wedgwood L, Scimone A, Blair IP, Parker G, Schofield PR (2006). Life events, first depression onset and the serotonin transporter gene. Br J Psychiatry 188, 210-5.
95. Willour VL, Chen H, Toolan J, Belmonte P, Cutler DJ, Goes FS, Zandi PP, Lee RS, MacKinnon DF, Mondimore FM, Schweizer B; Bipolar Disorder Phenome Group; NIMH Genetics Initiative Bipolar Disorder Consortium
96. DePaulo JR Jr, Gershon ES, McMahon FJ, Potash JB (2008). Family-based association of FKBP5 in bipolar disorder. Mol Psychiatry 14, 3, 261-8.
97. Zalsman G, Huang YY, Oquendo MA, Burke AK, Hu XZ, Brent DA, Ellis SP, Goldman D, Mann JJ (2006). Association of a triallelic serotonin transporter gene promoter region (5-HTTLPR) polymorphism with stressful life events and severity of depression. Am J Psychiatry 163, 9, 1588-93.
98. Zhang X, Beaulieu JM, Sotnikova TD, Gainetdinov RR, Caron MG (2004). Tryptophan hydroxylase-2 controls brain serotonin synthesis. Science 305, 5681, 217.
99. Zhang X, Gainetdinov RR, Beaulieu JM, Sotnikova TD, Burch LH, Williams RB, Schwartz DA, Krishnan KR, Caron MG (2005). Loss-of-function mutation in tryptophan hydroxylase-2 identified in unipolar major depression. Neuron 45, 1, 11-6.
100. Zhou Z, Peters EJ, Hamilton SP, McMahon F, Thomas C, McGrath PJ, Rush J, Trivedi MH, Charney DS, Roy A, Wisniewski S, Lipsky R, Goldman D (2005). Response to Zhang et al. (2005): loss-of-function mutation in tryptophan hydroxylase-2 identified in unipolar major depression. Neuron 45, 11-16. Neuron 48, 5, 702-3; author reply 705-6.
101. Zubenko GS, Hughes HB 3rd (2008). Effects of the G(-656)A variant on CREB1 promoter activity in a glial cell line: Interactions with gonadal steroids and stress. Am J Med Genet B Neuropsychiatr Genet 147B, 5, 579-85.
102. Zubenko GS, Hughes HB (2008). Effects of the G(-656)A variant on CREB1 promoter activity in a neuronal cell line: Interactions with gonadal steroids and stress. Mol Psychiatry 14, 390-397.
103. Zubenko GS, Hughes HB 3rd, Maher BS, Stiffler JS, Zubenko WN, Marazita ML (2002). Genetic linkage of region containing the CREB1 gene to depressive disorders in women from families with recurrent, early-onset, major depression. Am J Med Genet 114, 8, 980-7.
104. Zubenko GS, Hughes HB 3rd, Stiffler JS, Brechbiel A, Zubenko WN, Maher BS, Marazita ML (2003). Sequence variations in CREB1 cosegregate with depressive disorders in women. Mol Psychiatry 8, 6, 611-8.
105. Zubenko GS, Maher B, Hughes HB 3rd, Zubenko WN, Stiffler JS, Kaplan BB, Marazita ML (2003). Genome-wide linkage survey for genetic loci that influence the development of depressive disorders in families with recurrent, early-onset, major depression. Am J Med Genet B Neuropsychiatr Genet 123, 1, 1-18.